FU
Fudan University Shanghai Cancer Center at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Fudan University Shanghai Cancer Center takes part in 11 sessions at ESMO 2026 in Madrid. Its program centres on antibody-drug conjugates in cervical, breast and prostate cancer, alongside new drug combinations for urothelial, head and neck and thyroid cancers. Other sessions cover PSMA-targeted radioligand therapy and AI-assisted patient communication in prostate cancer, and multi-omics profiling of kidney cancer spread.
| Organization | ESMO 2026 Attendance |
|---|---|
FU Fudan University Shanghai Cancer Center Shanghai, China | |
Cancer hospital of Fudan University in Shanghai, China. | Abstract Fri Oct 23 16:15–16:20 Abstract Fri Oct 23 16:52–16:57 Abstract Fri Oct 23 17:10–17:15 Abstract Sat Oct 24 10:37–10:42 Abstract Sat Oct 24 10:45–10:50 Satellite Sat Oct 24 13:15–13:35 PSMA-targeted RLT in mCRPC: From guidelines to everyday decisions Genitourinary cancers Abstract Sun Oct 25 15:17–15:22 Abstract Mon Oct 26 09:12–09:17 Abstract Mon Oct 26 10:20–10:25 Abstract Mon Oct 26 10:25–10:30 Abstract Mon Oct 26 10:30–10:35 Abstract Mon Oct 26 10:52–10:57 Abstract Mon Oct 26 14:55–15:05 4241O - Multi-omics profiling defines drivers, organotropism, and predictive models in RCC metastasis Biomarkers & precision oncology |
Instantly find 20 buyers from Fudan University Shanghai Cancer Center
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction